Heidi Ko/LinkedIn
May 31, 2025, 06:31
Heidi Ko: Interesting Presentation During Metastatic Breast Cancer Session at ASCO 2025
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“Interesting presentation during Metastatic Breast Cancer session on how AI-assisted support led to increased accuracy and pathologist’s concordance in interpretation of HER2 IHC score, particularly in cases of HER2-low and ultralow cases.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 18:37
Aug 28, 2025, 18:29
Aug 28, 2025, 18:28
Aug 28, 2025, 18:24
Aug 28, 2025, 18:20